e-therapeutics plc announced the appointment of Alison Gallafent as Head of Intellectual Property for the Company. Alison Gallafent is a UK Chartered Patent Attorney and European Patent Attorney, who brings considerable intellectual property expertise to e-therapeutics, with over 20 years of experience in the pharmaceutical and biotech industries. Alison has previously worked as in-house Patent Counsel for a range of pharmaceutical companies, such as Merck and Co., Glaxo Wellcome, PLIVA and more recently as Head of IP at Silence Therapeutics plc. She has also held senior patent attorney roles in several leading international law firms and has successfully represented many international pharmaceutical companies in high profile and pivotal patent cases before the European Patent Office.